Skip to main content
. Author manuscript; available in PMC: 2024 Sep 16.
Published in final edited form as: Lancet HIV. 2023 Jul 12;10(8):e528–e542. doi: 10.1016/S2352-3018(23)00111-X

Figure 2: Estimated ever HIV testing among MSM over time, by region and country of Africa.

Figure 2:

Ever HIV testing among MSM in central and western Africa (A), eastern Africa (B), southern Africa (C), and the estimated proportion of MSM ever tested for HIV (D) in 2020, by country, estimated using a Bayesian logistic generalised linear mixed-effects model, with study-level, country-level, and region-level random effects. Points represent available study observations and their 95% CIs, coloured by country in which the study was conducted. The solid lines and shaded areas represent the estimated population-weighted region-level proportions and 95% CrI, respectively, which were estimated using only countries with available data (see appendix 2 p 49 for individual country trends and 95% CrI). MSM=men who have sex with men. CrI=credible interval.